Astellas commits up to $1.3 billion option on Audax’s cancer drug DAX‑044, not yet in human trialsCorroborated by 2 sources from 2 publishersglobalcrime4h agoTL;DRSources1Bloomberg Industrieshttps://www.bloomberg.com/news/articles/2026-10-27/astellas-bets-up-to-1-3-billion-on-cancer-drug-yet-to-enter-human-trials4h ago2Investing.com Newshttps://www.investing.com/news/company-news/astellas-secures-option-for-audaxs-cancer-drug-dax044-93CH-49772444h ago